semaglutide compounding news november 2025 September 15, 2025: Telehealth company must stop implying its compounded GLP-1 is FDA-approved, warns FDA – Partnership for Safe Medicines Compound versions of GLP-1 drugs

The TGA recently reported reported that all strengths of Mounjaro (tirzepatide) will be limited until 31 August 2024 due to unexpected high demand

Industry-leading product quality, sold in 130 countries around the world If you have any needs, please consult customer service FAQ Q1: How can you ensure the quality of your products

Some expect quick results, eat too little, or dont include enough protein in their diet

Additionally, customized doses also help ensure a more personalized weight loss

It remains in Phase 3 clinical trials through the TRIUMPH program, which includes multiple studies examining different patient populations and endpoints

5 Companies receiving warning letters have 15 working days to respond with a corrective action plan or a justification